Laurel Wealth Advisors, Inc. Amarin Corp Plcuk Transaction History

Laurel Wealth Advisors, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.13 - $3.69 $126,332 - $412,538	-111,799 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.85 - $3.73 $1,789 - $2,342	-628 Reduced 0.56%	111,799 $368,000
Q4 2021 Feb 14, 2022	BUY	$3.24 - $5.18 $14,424 - $23,061	4,452 Added 4.12%	112,427 $379,000
Q3 2021 Nov 12, 2021	BUY	$3.94 - $5.84 $571 - $846	145 Added 0.13%	107,975 $551,000
Q2 2021 Aug 16, 2021	BUY	$4.26 - $6.5 $59,158 - $90,265	13,887 Added 14.78%	107,830 $472,000
Q1 2021 May 14, 2021	BUY	$5.03 - $8.8 $3,913 - $6,846	778 Added 0.84%	93,943 $583,000
Q4 2020 Mar 03, 2021	BUY	$4.04 - $5.31 $3,898 - $5,124	965 Added 1.05%	93,165 $456,000
Q3 2020 Nov 13, 2020	BUY	$3.64 - $7.76 $36,400 - $77,600	10,000 Added 12.17%	92,200 $388,000
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $47,800 - $82,600	-10,000 Reduced 10.85%	82,200 $569,000
Q1 2020 May 15, 2020	BUY	$4.0 - $21.53 $31,180 - $167,826	7,795 Added 9.24%	92,200 $369,000
Q4 2019 Feb 13, 2020	SELL	$13.94 - $24.12 $354,006 - $612,527	-25,395 Reduced 23.13%	84,405 $1.81 Million
Q3 2019 Nov 13, 2019	BUY	$13.89 - $23.16 $363,779 - $606,560	26,190 Added 31.32%	109,800 $1.67 Million
Q2 2019 Aug 13, 2019	SELL	$16.27 - $20.51 $39,698 - $50,044	-2,440 Reduced 2.84%	83,610 $1.62 Million
Q1 2019 May 16, 2019	BUY	$12.61 - $22.33 $253,461 - $448,832	20,100 Added 30.48%	86,050 $1.79 Million
Q4 2018 Feb 13, 2019	BUY	$12.41 - $22.98 $688,134 - $1.27 Million	55,450 Added 528.1%	65,950 $897,000
Q3 2018 Nov 15, 2018	BUY	$2.45 - $16.27 $25,725 - $170,835	10,500 New	10,500 $170,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.